Inari Medical Management
Management criteria checks 2/4
Inari Medical's CEO is Drew Hykes, appointed in Jan 2023, has a tenure of 1.92 years. total yearly compensation is $5.08M, comprised of 13.8% salary and 86.2% bonuses, including company stock and options. directly owns 0.65% of the company’s shares, worth $20.98M. The average tenure of the management team and the board of directors is 1.9 years and 5.1 years respectively.
Key information
Drew Hykes
Chief executive officer
US$5.1m
Total compensation
| CEO salary percentage | 13.8% |
| CEO tenure | 1.9yrs |
| CEO ownership | 0.6% |
| Management average tenure | 1.9yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
Inari Medical, Inc. (NASDAQ:NARI) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable
Nov 07
Investors Interested In Inari Medical, Inc.'s (NASDAQ:NARI) Revenues
Sep 23Inari Medical: A Touch Of Uncertainty And Overvaluation
Jul 05At US$43.23, Is It Time To Put Inari Medical, Inc. (NASDAQ:NARI) On Your Watch List?
Jun 18Market Participants Recognise Inari Medical, Inc.'s (NASDAQ:NARI) Revenues Pushing Shares 26% Higher
May 23Is Inari Medical, Inc. (NASDAQ:NARI) Trading At A 29% Discount?
May 02Inari Medical: Buy On Growing TAM
Mar 27Why We're Not Concerned Yet About Inari Medical, Inc.'s (NASDAQ:NARI) 25% Share Price Plunge
Mar 08Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?
Dec 14A Look At The Fair Value Of Inari Medical, Inc. (NASDAQ:NARI)
Oct 23Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business
Sep 18Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?
Aug 14Inari Medical, Inc. (NASDAQ:NARI) Shares Could Be 23% Above Their Intrinsic Value Estimate
Jul 25We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth
Jun 18Inari Medical, Inc.'s (NASDAQ:NARI) Price In Tune With Revenues
Apr 17CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$79m |
| Jun 30 2024 | n/a | n/a | -US$57m |
| Mar 31 2024 | n/a | n/a | -US$24m |
| Dec 31 2023 | US$5m | US$700k | -US$2m |
| Sep 30 2023 | n/a | n/a | -US$3m |
| Jun 30 2023 | n/a | n/a | -US$16m |
| Mar 31 2023 | n/a | n/a | -US$28m |
| Dec 31 2022 | US$3m | US$500k | -US$29m |
| Sep 30 2022 | n/a | n/a | -US$22m |
| Jun 30 2022 | n/a | n/a | -US$15m |
| Mar 31 2022 | n/a | n/a | -US$758k |
| Dec 31 2021 | US$3m | US$450k | US$10m |
| Sep 30 2021 | n/a | n/a | US$16m |
| Jun 30 2021 | n/a | n/a | US$25m |
| Mar 31 2021 | n/a | n/a | US$17m |
| Dec 31 2020 | US$829k | US$384k | US$14m |
| Sep 30 2020 | n/a | n/a | US$7m |
| Jun 30 2020 | n/a | n/a | US$1m |
| Mar 31 2020 | n/a | n/a | US$4m |
| Dec 31 2019 | US$654k | US$316k | -US$1m |
Compensation vs Market: Drew's total compensation ($USD5.08M) is about average for companies of similar size in the US market ($USD6.65M).
Compensation vs Earnings: Drew's compensation has increased whilst the company is unprofitable.
CEO
Drew Hykes (51 yo)
1.9yrs
Tenure
US$5,083,365
Compensation
Mr. Andrew J. Hykes, also known as Drew, served as Chief Operating Officer at Inari Medical, Inc. since October 2020 until December 2022 and serves as its President and Director since January 2023 and serv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.9yrs | US$5.08m | 0.65% $ 21.0m | |
| Chief Medical Officer | 5.4yrs | US$2.50m | 0.47% $ 15.1m | |
| Senior Vice President of Operations | 1.8yrs | no data | no data | |
| Vice President of Finance & Accounting | less than a year | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| General Counsel & Secretary | 4.1yrs | no data | no data | |
| Senior Vice President of Marketing | 5yrs | no data | no data | |
| Senior VP of Sales & Senior VP of U.S. Sales | less than a year | no data | no data | |
| Senior VP & GM of LimFlow | 2.9yrs | no data | no data | |
| Senior Vice President of Engineering | no data | no data | no data | |
| Chief Medical Officer of LimFlow | less than a year | no data | no data |
1.9yrs
Average Tenure
51yo
Average Age
Experienced Management: NARI's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.9yrs | US$5.08m | 0.65% $ 21.0m | |
| Independent Chair of the Board | 13.3yrs | US$266.47k | 5.27% $ 171.2m | |
| Independent Director | 13.3yrs | US$230.97k | 0.92% $ 29.8m | |
| Independent Director | 3.2yrs | US$218.47k | 0.011% $ 349.0k | |
| Independent Director | 5.1yrs | US$220.51k | 0.031% $ 1.0m | |
| Director | 9.8yrs | US$198.43k | 0.72% $ 23.4m | |
| Independent Director | 5.1yrs | US$235.93k | 0.059% $ 1.9m | |
| Independent Director | 2.8yrs | US$220.97k | 0.012% $ 386.0k | |
| Independent Director | 3.5yrs | US$220.93k | 0.0095% $ 308.1k |
5.1yrs
Average Tenure
57yo
Average Age
Experienced Board: NARI's board of directors are considered experienced (5.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:20 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Inari Medical, Inc. is covered by 20 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Rescott | Baird |
| null null | Baird |
| Nisala Weerasuriya | Berenberg |